Target intelligence / Profile preview

ULK4 pseudogene 3 (ULK4P3)

Target
ULK4P3
Molecular classification
Pseudogene, Other
01

Overview

ULK4 pseudogene 3 (ULK4P3) is formally annotated as a pseudogene related to the ULK4 gene. Unlike ULK4, which is studied for its role in neurogenesis and neuropsychiatric disorders[1][4][7], ULK4P3 has no documented function, no known protein product, and is not considered a receptor, enzyme, transporter, or other therapeutic target. There is minimal literature describing ULK4P3, and its only apparent scientific role is as a reference point or annotation in genomic research[3]. Scientific investigations and therapeutic interest focus on ULK4, and not on ULK4P3. ULK4P3 is a pseudogene with no functional protein product, no known biological role, and is not considered a current or potential therapeutic target. There is something wrong with designating it as a target for drug discovery or clinical research. References focus on ULK4 proper, not the ULK4P3 pseudogene[1][2][3].

Other names
ULK4P3ULK4 pseudogene 3D-X
02

Mechanism of action

None known. No approved or investigational drug mechanisms target ULK4P3.

03

Biological functions

No known or established biological functions for ULK4P3. Pseudogenes typically do not encode functional proteins, though some may exert regulatory roles (such as antisense RNA or miRNA sponges), but such roles are not reported for ULK4P3
04

Disease associations

No known disease associations or evidence that ULK4P3 is implicated in human disease
05

Safety considerations

None reported. As this is not an established target and does not encode a protein, no safety concerns are relevant.
06

Interacting drugs

None known. No drugs are reported to interact with ULK4P3.
07

Biomarkers

None known. ULK4P3 is not currently used as a biomarker for patient selection, efficacy monitoring, or therapeutic safety.

Beyond the preview

Go deeper on ULK4 pseudogene 3 (ULK4P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ULK4 pseudogene 3 (ULK4P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call